Management of depressive symptoms in schizophrenia: a pooled, post hoc analysis from the asenapine development program

被引：0
|
作者：
Castle, D. [1 ]
Jensen, J. K. S. [2 ]
机构：
[1] Univ Western Australia, Melbourne, Vic, Australia
[2] H Lundbeck & Co AS, Dept Biostat, Valby, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70797-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.f.019
引用
收藏
页码：S502 / S503
页数：2
相关论文
共 50 条
  • [21] Hormonal effects of cariprazine: Post hoc analysis of pooled data from schizophrenia studies for sexual dysfunction and prolactin changes
    Barabassy, A.
    Szatmari, B.
    Laszlovszky, I.
    Harsanyi, J.
    Burjan, A.
    Reti-Gyorffy, D.
    Earley, W.
    Patel, M.
    Nemeth, G.
    EUROPEAN PSYCHIATRY, 2018, 48 : S522 - S522
  • [22] Behavioural symptoms in Alzheimer's disease: Pooled, post hoc analysis of patients receiving galantamine
    Herrmann, N
    Rabheru, K
    Wang, J
    Binder, C
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 324 - 324
  • [23] Efficacy of Karxt on Negative Symptoms in Acute Schizophrenia: A Post Hoc Analysis of Participants With Prominent Negative Symptoms
    Horan, William
    Claxton, Amy
    Targum, Steven D.
    Yohn, Samantha E.
    Kaul, Inder
    Sawchak, Sharon
    Miller, Andrew C.
    Paul, Steven M.
    Brannan, Stephen K.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S268 - S269
  • [24] Impact of fingolimod on depressive symptoms: post-hoc data from the EPOC trial
    Hunter, S. F.
    Hollander, E.
    Miller, D. M.
    Cutter, G.
    Agashivala, N.
    Li, S.
    Chin, P.
    Hashmonay, R.
    Barbato, L. M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 470 - 470
  • [25] A pooled post-hoc analysis of change in depressive symptoms in patients with refractory partial-onset seizures treated with eslicarbazepine acetate as adjuntive therapy
    Costa, R.
    Magalhaes, L.
    Gama, H.
    Oliveira, I.
    Moreira, J.
    Rocha, F.
    Ikedo, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 337 - 338
  • [26] Low Interstitial Lung Disease Event Rate in Patients with Rheumatoid Arthritis: Pooled Post Hoc Analysis of Data from the Tofacitinib Clinical Development Program
    Citera, Gustavo
    Mysler, Eduardo
    Madariaga, Hugo
    Cardiel, Mario H.
    Castaneda, Oswaldo
    Fischer, Aryeh
    Richette, Pascal
    Chartrand, Sandra
    Park, Jin Kyun
    Strengholt, Sander
    Rivas, Jose L.
    Thorat, Amit
    Girard, Tanya
    Kwok, Kenneth
    Wang, Lisy
    Ponce de Leon, Dario
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [27] LOW INTERSTITIAL LUNG DISEASE EVENT RATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED POST HOC ANALYSIS OF DATA FROM THE TOFACITINIB CLINICAL DEVELOPMENT PROGRAM
    Citera, Gustavo
    Mysler, Eduardo
    Madariaga, Hugo
    Cardiel, Mario H.
    Castaneda, Oswaldo
    Fischer, Aryeh
    Richette, Pascal
    Chartrand, Sandra
    Park, Jin Kyun
    Strengholt, Sander
    Luis Rivas, Jose
    Thorat, Amit
    Girard, Tanya
    Kwok, Kenneth
    Wang, Lisy
    Ponce de Leon, Dario
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S42 - S42
  • [28] Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials
    Armin Szegedi
    Jun Zhao
    Arjen van Willigenburg
    Kari R Nations
    Mary Mackle
    John Panagides
    BMC Psychiatry, 11
  • [29] Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials
    Szegedi, Armin
    Zhao, Jun
    van Willigenburg, Arjen
    Nations, Kari R.
    Mackle, Mary
    Panagides, John
    BMC PSYCHIATRY, 2011, 11
  • [30] Cariprazine for Negative Symptoms of Schizophrenia: Pooled Post Hoc Analysis of 2 Randomized, Double-Blind, Placebo- and Active-Controlled Trials
    Earley, Willie
    Durgam, Suresh
    Debelle, Marc
    Laszlovszky, Istvan
    Lu, Kaifeng
    Nasrallah, Henry
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S233 - S234
12345